Stay updated on Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.

Latest updates to the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2, reflecting a minor version update to the page.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page now shows a newer site revision label (v3.6.2) replacing the previous v3.6.0. This appears to be a minor UI/site maintenance update and does not affect the study details or data displayed on the page.SummaryDifference0.0%

- Check41 days agoChange DetectedEnrollment status updated to no longer recruiting, affecting participant access and study enrollment. The page also added new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated labels and revision tag (v3.6.0) alongside a formatting change for Intervention/Treatment.SummaryDifference0.3%

- Check48 days agoChange DetectedA new revision tag (Revision: v3.5.5) was added, replacing the previous v3.5.4, indicating an updated version of the page.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page shows Revision: v3.5.4 instead of the previous v3.5.3. This indicates an updated release/version identifier for the page rather than a substantive content change.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page’s footer software/version marker was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site release rather than content changes to the clinical study information.SummaryDifference0.0%

Stay in the know with updates to Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.